*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
The Potential Use of Nitazoxanide in the Treatment of Cutaneous Leishmaniasis: In-Vitro Assays Against Leishmania Tropica

Author: AISHAH E ALBALAWI, HAMDAN I ALMOHAMMED, AMAL KHUDAIR KHALAF, ABDULLAH D ALANAZI, ALI MOGHADDAM, MASSUMEH NIAZI, HOSSEIN MAHMOUDVAND
Abstract: Here we designed to assess the effect of nitazoxanide (NTZ) alone and along with meglumine antimoniate (MA) against amastigote and promastigote forms of Leishmania tropica in vitro. The antileishmanial activity of effects of NTZ alone and along with MA on L. tropica promastigote and amastigote forms have been determined via a colorimetric MTT method and on the J774-A1 macrophage cells, respectively. Also, the effect of NTZ on the infection rate of Leishmania to J774-A1 cells was determined. The results of the 50% inhibitory concentrations (IC50) showed that NTZ + MA (25.8 ± 1.57 µg/ml) possess a more anti-leishmanial effect than MA (65.3 ± 3.12 µg/ml) or MTX alone (80.2 µg/ml) on promastigotes of L. tropica. The MTX combined with MA triggered a significant reduction (P<0.05) in the mean number of amastigotes forms in J774-A1 cells in comparison with control group. The results also demonstrated that rate of infectivity of promastigotes was considerably (P<0.05) decreased after it pre-incubation with NTZ. The obtained findings revealed that the great effectiveness and a synergistic effect of NTZ alone and along with MA on the growth of L. tropica promastigote and amastigote forms. However, further clinical studies are mandatory to examine this synergistic effect on a therapeutic scale.
Keyword: cutaneous leishmaniasis, combination therapy, promastigote, amastigote, infectivity rate
DOI: https://doi.org/10.31838/ijpr/2021.13.02.502
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free